UnitedHealth Group's stock price rises on stable Medicare Advantage ratings and 2025 earnings guidance despite regulatory scrutiny and mixed insider trading activity.
SelectQuote faces DOJ and class-action lawsuits over alleged deceptive Medicare Advantage sales practices, impacting stock prices and raising compliance concerns.
UnitedHealth expects 78% of members in Medicare Advantage plans rated four stars or higher for 2026, supporting government reimbursements and financial outlook amid cost pressures.
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
UnitedHealth plans to have most Medicare Advantage enrollees in four-star plans by 2026, while AI infrastructure deals influence technology and semiconductor markets, impacting health insurers and chipmakers alike.
Study reveals Medicare Advantage beneficiaries face longer hospital stays post-pandemic, driven by skilled nursing facility shortages and administrative barriers, impacting healthcare operations and costs.
New MedPAC analysis finds increased Medicare Advantage enrollment has no significant negative effect on hospital profit margins, challenging claims from hospital groups.
UnitedHealth Group anticipates 78% of Medicare Advantage members will be enrolled in plans rated four stars or above in 2024, enhancing eligibility for Medicare bonus payments and supporting its health insurance segment.
UnitedHealth expects about 78% of its Medicare Advantage members to be enrolled in plans rated four stars or above in 2027, signaling strong quality performance under CMS metrics.
Elevance Health and leading insurers recalibrate Medicare Advantage plans and Part D coverage amid rising costs and regulatory shifts, focusing on risk management and compliance.
